OR WAIT 15 SECS
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Silver Spring, Md. - The FDA Dermatologic and OphthalmicAdvisory Committee on May 23 strongly recommended approval of alefacept,a systemic drug for the treatment of chronic plaque psoriasis.
Related Content:
News